PMID- 19110759 OWN - NLM STAT- MEDLINE DCOM- 20090219 LR - 20151119 IS - 1881-6096 (Print) IS - 1881-6096 (Linking) VI - 60 IP - 12 DP - 2008 Dec TI - [Case of anti P/Q type VGCC antibody positive small lung cell carcinoma that occured with subacute cerebellar degeneration, Lambert-Eaton myasthenic syndrome, and brainstem encephalitis]. PG - 1470-4 AB - A 62-year-old man was admitted to our hospital because of rapidly progressive dysarthria, truncal ataxia, and gait disturbance. High titers of the ProGRP and anti-P/Q-type VGCC antibody were detected in the serum. High accumulation of [18F] was detected at the hilus of the left lung on [18F]-FDG-PET scan. A high-frequency repetitive stimulation test of the median nerve yielded an incremental response. On the basis of these findings, a diagnosis of paraneoplastic cerebellar degeneration (PCD) and Lambert-Eaton myasthenic syndrome (LEMS) associated with small cell lung carcinoma (SCLC) was diagnosed. After intravenous immunoglobulin therapy (IVIg), methylprednisolone (m-PSL) pulse therapy, and other multidisciplinary concurrent treatments, a partial regression of the SCLC and a significant improvement in neurological symptoms were observed. However, ataxia relapsed and brainstem encephalitis developed 6 months later. A marginal improvement in neurological symptoms was observed with IVIg, m-PSL pulse therapy, and intravenous cyclophosphamide pulse therapy (IVCY). SCLC also recurred later. We hypothesized that VGCC of the brainstem was damaged by anti-P/Q-type VGCC antibody. FAU - Nagayama, Shigemi AU - Nagayama S AD - Division of Neurology, Yanagawa Rehabilitation Hospital, Japan. FAU - Koike, Fumihiko AU - Koike F FAU - Sakai, Tetsuo AU - Sakai T FAU - Antoku, Yasunobu AU - Antoku Y FAU - Yukitake, Motohiro AU - Yukitake M FAU - Kuroda, Yasuo AU - Kuroda Y LA - jpn PT - Case Reports PT - English Abstract PT - Journal Article PL - Japan TA - Brain Nerve JT - Brain and nerve = Shinkei kenkyu no shinpo JID - 101299709 RN - 0 (Autoantibodies) RN - 0 (Biomarkers, Tumor) RN - 0 (Calcium Channels, P-Type) RN - 0 (Calcium Channels, Q-Type) RN - 0 (Peptide Fragments) RN - 0 (Recombinant Proteins) RN - 0 (pro-gastrin-releasing peptide (31-98)) SB - IM MH - Autoantibodies/*blood MH - Biomarkers, Tumor/*blood MH - *Brain Stem MH - Calcium Channels, P-Type/*immunology MH - Calcium Channels, Q-Type/*immunology MH - Combined Modality Therapy MH - Encephalitis/diagnosis/*etiology/therapy MH - Humans MH - Lambert-Eaton Myasthenic Syndrome/diagnosis/*etiology/therapy MH - Lung Neoplasms/*complications/diagnosis/immunology/therapy MH - Male MH - Middle Aged MH - Paraneoplastic Cerebellar Degeneration/diagnosis/*etiology/therapy MH - Peptide Fragments/blood MH - Positron-Emission Tomography MH - Recombinant Proteins/blood MH - Small Cell Lung Carcinoma/*complications/diagnosis/immunology/therapy MH - Treatment Outcome EDAT- 2008/12/30 09:00 MHDA- 2009/02/20 09:00 CRDT- 2008/12/30 09:00 PHST- 2008/12/30 09:00 [entrez] PHST- 2008/12/30 09:00 [pubmed] PHST- 2009/02/20 09:00 [medline] PST - ppublish SO - Brain Nerve. 2008 Dec;60(12):1470-4.